Immunic
IMUX
63 hedge funds and large institutions have $148M invested in Immunic in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 14 closing their positions.
63% more call options, than puts
Call options by funds: $1.51M | Put options by funds: $927K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.3% less ownership
Funds ownership: 4.7% → 4.39% (-0.3%)
0% less capital invested
Capital invested by funds: $149M → $148M (-$492K)
9% less funds holding
Funds holding: 69 → 63 (-6)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.88M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.76M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$823K |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$775K |
| 5 |
OCA
Otter Creek Advisors
Palm Beach Gardens,
Florida
|
+$594K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$3.73M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.58M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.29M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.95M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$932K |
IMUX Hedge Fund Activity: Q1 2021 in Review
63 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2021, worth a combined $148M — down 0.33% from $149M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of IMUX and 8 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 17 added.
The largest buyer was Point72 Asset Management, adding an estimated $3.88M. The largest seller was Altium Capital Management, exiting entirely with an estimated $3.73M sold.
- 63 institutional investors held Immunic (IMUX) as of Q1 2021, down from 69 in Q4 2020.
- Funds reported $148M of Immunic stock for Q1 2021, down 0.33% quarter-over-quarter.
- 8 funds opened new Immunic positions in Q1 2021 and 14 closed out, a net change of -6 holders.
- The largest Immunic buyer in Q1 2021 was Point72 Asset Management, an estimated $3.88M added.
- The largest Immunic seller in Q1 2021 was Altium Capital Management, an estimated $3.73M sold.
Based on aggregated 13F filings for Q1 2021.